Fundz

Dmc Biotechnologies, Inc. reported raising $22,400 in an initial SEC Form D filing, from an offering of $22,400

PRIVATEJan 28, 2021

Amount Raised

$22,400

$22,400 sold, per SEC Form D (first sale Jan 28, 2021)

Round Type

Venture

BoulderBiotechnology

Quick answer

DMC Biotechnologies raised $22,400 in a funding round, dated January 28, 2021. DMC Biotechnologies is based in Boulder, Colorado, United States.

How much did DMC Biotechnologies raise?
DMC Biotechnologies raised $22,400 in a funding round on January 28, 2021.
What does DMC Biotechnologies do?
DMC is a U.S. biomanufacturer seeking to transform how the world makes chemicals.
Where is DMC Biotechnologies based and how big is it?
DMC Biotechnologies is based in Boulder, Colorado, United States. Fundz records about 51 employees.
Who are the decision-makers at DMC Biotechnologies?
Fundz holds 2 contacts at DMC Biotechnologies. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as DMC Biotechnologies that raised within 45 days of this round, from Fundz verified event records.

Who to call at DMC Biotechnologies, and when

A new round usually means DMC Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DMC Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DMC Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DMC Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DMC Biotechnologies

Location

2477 55th Street, Suite 120

Boulder, Colorado, United States

About

DMC is a U.S. biomanufacturer seeking to transform how the world makes chemicals. The company leverages precision fermentation and synthetic biology to decarbonize chemicals, deliver more sustainable and natural food ingredients and supplements, and improve the security of global supply chains. It’s platform technology, Dynamic Metabolic Control™, simplifies biology, and enables predictable, robust, and more efficient fermentation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DMC Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts15 people are listed at DMC Biotechnologies. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DMC Biotechnologies's next move

See what Strategic adds

DMC Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.